Seroprevalence of anti-SARS-CoV-2 antibodies and risk factors among healthy blood donors in Luanda, Angola

[1] Zhu N(2020)A Novel Coronavirus from Patients with Pneumonia in China, 2019 N Engl J Med 382 727-33

[2] Zhang D(2020)Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia N Engl J Med 382 1199-207

[3] Wang W(2020)Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China Allergy Eur J Allergy Clin Immunol. 75 1730-41

[4] Li X(2020)Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Lancet 395 1054-62

[5] Yang B(2020)Clinical Characteristics of Coronavirus Disease 2019 in China N Engl J Med 382 1708-20

[6] Song J(2020)Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil Rev Saude Publica 54 1-10

[7] Li Q(2020)Coronavirus Disease 2019: Coronaviruses and blood safety Transfus Med Rev. 34 75-80

[8] Guan X(2021)Sociodemographic characteristics and risk factors related to SARS-CoV-2 infection in Luanda, Angola PLoS One 16 1-10

[9] Wu P(2020)Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020 JAMA Intern Med 180 1776-86

[10] Wang X(2020)Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study Lancet 396 535-44

[1] Zhu N(2020)A Novel Coronavirus from Patients with Pneumonia in China, 2019 N Engl J Med 382 727-33

[2] Zhang D(2020)Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia N Engl J Med 382 1199-207

[3] Wang W(2020)Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China Allergy Eur J Allergy Clin Immunol. 75 1730-41

[4] Li X(2020)Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Lancet 395 1054-62

[5] Yang B(2020)Clinical Characteristics of Coronavirus Disease 2019 in China N Engl J Med 382 1708-20

[6] Song J(2020)Seroprevalence of anti-SARS-CoV-2 among blood donors in Rio de Janeiro, Brazil Rev Saude Publica 54 1-10

[7] Li Q(2020)Coronavirus Disease 2019: Coronaviruses and blood safety Transfus Med Rev. 34 75-80

[8] Guan X(2021)Sociodemographic characteristics and risk factors related to SARS-CoV-2 infection in Luanda, Angola PLoS One 16 1-10

[9] Wu P(2020)Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020 JAMA Intern Med 180 1776-86

[10] Wang X(2020)Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study Lancet 396 535-44